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Abstract
Background: The objective of this study was to evaluate the validity of self reported criteria of Metabolic
Syndrome (MS) in the SUN (Seguimiento Universidad de Navarra) cohort using their medical records as the gold
standard.
Methods: We selected 336 participants and we obtained MS related data according to Adult Treatment Panel III
(ATP III) and International Diabetes Federation (IDF). Then we compared information on the self reported diagnosis
of MS and MS diagnosed in their medical records. We calculated the proportion of confirmed MS, the proportion
of confirmed non-MS and the intraclass correlation coefficients for each component of the MS.
Results: From those 336 selected participants, we obtained sufficient data in 172 participants to confirm or reject
MS using ATP III criteria. The proportion of confirmed MS was 91.2% (95% CI: 80.7- 97.1) and the proportion of
confirmed non-MS was 92.2% (95% CI: 85.7-96.4) using ATP III criteria. The proportion of confirmed MS using IDF
criteria was 100% (95% CI: 87.2-100) and the proportion of confirmed non-MS was 97.1% (95% CI: 85.1-99.9). Kappa
Index was 0.82 in the group diagnosed by ATP III criteria and 0.97 in the group diagnosed by IDF criteria. Intraclass
correlation coefficients for the different component of MS were: 0.93 (IC 95%:0.91- 0.95) for BMI; 0.96 (IC 95%: 0.93-
0.98) for waist circumference; 0.75 (IC 95%: 0.66-0.82) for fasting glucose; 0.50 (IC 95%:0.35-0.639) for HDL
cholesterol; 0.78 (IC 95%: 0.70-0.84) for triglycerides; 0.49 (IC 95%:0.34-0.61) for systolic blood pressure and 0.55 (IC
95%: 0.41-0.65) for diastolic blood pressure.
Conclusions: Self-reported MS based on self reported components of the SM in a Spanish cohort of university
graduates was sufficiently valid as to be used in epidemiological studies.
Introduction
Visceral obesity, insulin resistance, high blood pressure,
and dyslipidemia are some of the characteristic abnorm-
alities of the metabolic syndrome (MS). The association
of these alterations confers a high risk of atherosclerosis
and cardiovascular disease, more than the sum of the
individual risks [1]. It is estimated that MS, by its conse-
quences, including type 2 diabetes and cardiovascular
disease, is the first cause of death in women and the
second cause of death in men in our society [2].
A unified definition of MS is needed to detect this
entity in the general population [3-5]. The high preva-
lence (20 to 25% of the world population [6,7]), the
dramatic increase over last years [8] and socio-sanitary
impact in developed countries is resulting in a global
epidemic of MS [9]. In Spain the prevalence of MS var-
ies between 11% and 24%, depending on the different
studies [10-14].
An epidemiological questionnaire is a useful tool to
study MS in the population. The questionnaire is useful
in assessing the characteristics and distribution of MS in
the population and then analyzing epidemiological
results and drawing conclusions. Sometimes, the only
feasible way of studying these populations is to rely on
self-reported data of the outcome. As a consequence, it
is of the utmost importance to assess the validity of that
information. Self-reported diagnosis of MS could not be
useful in populations with low cultural level but could
be enough valid in a cohort of university graduates.
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reported diagnosis of MS in a sample of the participants
in the Seguimiento Universidad de Navarra (SUN, Uni-
versity of Navarra Follow-up) study, a cohort study in
Spain. In this sample we compared the self-reported
data in the questionnaire with the data obtained from
their medical records as the gold standard.
Material and methods
The SUN Project is a dynamic cohort of university grad-
u a t e s ,r e c r u i t e da n df o l l o w e du pt h r o u g hm a i l e dq u e s -
tionnaires. Beginning in December 1999 [15], the main
objective of the study was to assess the association
between a Mediterranean dietary pattern and the risk of
cardiovascular disease, diabetes, obesity, MS, and other
chronic disease. To select the volunteers, all graduates
of the University of Navarra, registered nurses from
some Spanish provinces, and university graduates from
other colleges and associations received a mailed ques-
tionnaire and a letter of invitation to participate in the
SUN study. A response to the initial questionnaire was
considered as informed consent to participate in the
study. Then, every 2 years, a follow-up questionnaire is
mailed to each participant, gathering information about
new medical diagnoses and changes in exposures of
interest. Part of this information is self-reported and
participants obtain it from their blood test and medical
check-ups that they routinely undergo in Spain by their
occupational physicians (blood pressure, levels of trigly-
cerides, fasting glucose, high-density lipoprotein, choles-
terol, etc.). The questionnaire includes questions about
previous and new diagnoses and changes in medications.
The diagnosis of MS was not present in the question-
naire. We preferred to ask separately about each of the
MS components to avoid an underestimation and to be
able to obtain more information (supplementary data
file - Additional file 1).
T h eS U NS t u d yw a sa p p r o v e db yt h eI n s t i t u t i o n a l
Review Board of the University of Navarra.
Validation of the study
All participants with MS self reported criteria in the
SUN questionnaire and with medical records in the
Clinica Universidad de Navarra (CUN) were selected (n
= 132). Another random sample of 204 participants with
no MS criteria in the questionnaire and medical record
in the CUN was taken. We calculated this sample size
for a single proportion [16] (for a confidence interval of
95%) with a desired precision of the confidence interval
of 0.04. Among 336 selected participants, we obtained
sufficient data from the medical records to confirm or
reject MS in 172 participants. Medical record informa-
tion and questionnaire information was obtained by a
different investigator. Thus, the researcher who obtained
information from the medical record (MTB-L) did not
know if each participant had reported MS or not. Ques-
tionnaires were answered in 2006 and the information
from the medical record was obtained between 2005
and 2006.
To conduct the validation we compared the informa-
tion from the questionnaire with the information from
the medical record. The ATP III [3] (Adult Treatment
Panel III) criteria were applied for the MS classification
in the questionnaire and diagnosis in the medical report.
In the sensitivity analysis, IDF [4] (International Dia-
betes Federation) criteria were applied too.
For ethical reasons, the identity of the participants was
masked. This was the process: a first investigator (C de
la F) selected a list with only an identification number,
the name and the surname of each participant (self-
reported MS criteria were excluded), a second investiga-
tor (MTB-L) obtained the medical information about
MS from the participants medical record, a third investi-
gator (MB-R) did the analysis between the serf-reported
data and the medical history data only with the partici-
pant identification number (anonymous).
In this way a) any investigator could not know both
information (self-reported and measured information)
and the participant identity at the same time b) the
investigator who obtained the information from the
medical record (MTB-L) was blind with respect to self-
reported information; c) the investigator who performed
the statistical analysis never knew the participants iden-
tity; d) in the moment of answer the questionnaire, par-
ticipants did not know that we will obtain information
from their medical records. Laboratory test results from
the medical record and self-reported information were
both determined after fasting. Blood pressure, weight
and height were measured routinely in the clinic.
Definition of self-reported MS and confirmed MS
We considered that a participant reported MS if the cri-
teria of MS according to ATP III criteria were present
in the questionnaire. On the other hand, we classified a
participant as confirmed MS if he or she presented cri-
teria of MS according to ATP III criteria in his/her
medical record.
In participants who had normal values of blood pres-
sure, HDL-cholesterol, triglycerides or fasting glycaemia,
the medical treatment was considered in order to clas-
sify correctly the participants and avoid effect of insulin,
lipid-lowering or antihypertensive drugs. Then the same
analyses were made using the IDF [4] criteria.
Statistical analysis
The proportion of subjects with confirmed MS (Positive
predictive value, PPV) was calculated as the number of
participants who reported MS and this diagnosis was
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by the total number of people who reported MS (total
positives). In the same way, the proportion of confirmed
non MS (Negative predictive value, NPV) was calculated
as the number of participants who reported no MS and
this diagnosis was confirmed by the medical history
(true negatives) divided by the total number of people
who reported no MS (total negatives).
The different characteristics (age, sex, body mass
index, university career) between the proportion of cases
with MS and without confirmed MS were studied using
the Fisher’s exact test [17].
The coincidence between the self-reported MS and
confirmed MS was evaluated by the Kappa index. This
index was calculated with ATP III and IDF criteria.
To calculate sensitivity and specificity of a self-
reported diagnose of MS, the expected distribution of
true and false positive and negative cases in the sample
were estimated through sampling fractions and observed
percentage of confirmed diagnoses to estimate the pre-
valence of MS in our population. We estimated the pre-
valence of MS in our population as 20%, which is
similar to the prevalence reported by descriptive studies
in Spain [10-13]. The Spearman and the Pearson corre-
lation coefficients and intraclass correlation coefficients
were calculated for continuous variables.
Results
We included 57 self-reported MS and 115 self-reported
non MS in our analyses. 59.9% were men and 40.1%
were women. Mean age was 53.3 years (95% CI: 51.1-56
years), 59 among men and 44 among women. Declared
MS increased with age and was higher in men than in
women (85% and 15%, respectively). There were no dif-
ferences in the SM reported between different university
degrees. Table 1 shows the main characteristics of the
study participants.
We confirmed 52 (91.22%) of the 57 self-reported MS
(95% CI 80.70-97,09%). Among 115 participants who
did not report a MS diagnosis in the questionnaires, 106
(92.17%, 95% CI 85.66-96.36%) could be considered
non-MS according to our gold standard (Table 2). Table
2s h o w sd i a g n o s i so fM Sa n dv a l i d i t yo fs e l f - r e p o r t e d
MS according to relevant variables.
Based on the assumption that the cohort prevalence of
MS was 20%, we estimated a sensitivity of 66% and a
specificity of 98% to detect MS using self-reported data.
The Kappa index coefficient between serf-reported MS
and confirmed MS was 0.82 (95% CI 0.73-0.91%) using
ATP III criteria and 0.97 (95% IC: 0.90-1) using IDF
criteria.
On the other hand, we analyzed the correlation
between component elements of the diagnostic criteria
of MS. The best correlation was found for body mass
index (BMI). Blood pressure was the variable with the
worse correlation. However, all self-reported compo-
nents of MS had a strong positive correlation according
to the available MS components in medical records
(Table 3).
Discussion
Our findings showed an acceptable degree of confirma-
tion of self-reported diagnoses of MS. Sensitivity was
only moderate but specificity and predictive values were
very high. In addition, the correlation between the com-
ponent variables of MS was fair enough to be used in
epidemiological studies.
In general, data recorded o fM Sl i k eab i n a r ye x p r e s -
sion (presence or absence of MS) has its limitations,
and it is better to obtain information of the compo-
nent elements of the diagnostic criteria of MS (HDL-
cholesterol, LDL-cholesterol, fasted glycaemia, blood
pressure and waist circumference) to avoid an underes-
timation. In the SHIELD [18] study (Study to Help
Improve Early evaluation and management of risk fac-
tors Leading to Diabetes) prevalence of self-reported
MS was studied in 211.097 participants. SHIELD
respondents were asked if they had ever been told by a
doctor, nurse or other health professional that they
had MS or syndrome X. The proportion of respon-
dents reporting a diagnosis of MS was estimated as the
prevalence of MS in SHIELD. Only 0.6% of the total
population reported a MS diagnosis. In contrast,
NHANES [19] (n = 10,780) data using clinical and
l a b o r a t o r yc r i t e r i ai n d i c a t e daM Sp r e v a l e n c eo f2 5 . 9 %
in the adult population. The SHIELD respondents and
NHANES participants belong to similar populations
according to age, sex and ATP III criteria.
SHIELD study evidenced the lack of knowledge about
MS in the general population and especially in high risk
patients (obese, diabetic, hypertensive). In these risk
populations the self-reported MS was similar to the gen-
eral population. Therefore in our study we decided to
ask for MS criteria to get more information and avoid
an underestimation of the true prevalence.
In the SUN cohort we have reported a previous vali-
dation of the MS components [20]. In the present study
we wanted to validate not only the MS components, but
also the MS according to the two more important cri-
teria (IDF and ATP III). We collected continuous data
of blood pressure, HDL-cholesterol, triglycerides, weight,
height, and waist circumference. From this data MS was
defined according with ATP III and IDF criteria.
Positive predictive value (91.2%) and negative predic-
tive value (92.2%) are an evidence of the good validity of
self-reported questionnaire to detect the presence or the
absence of MS in this population of university
graduates.
Barrio-Lopez et al. BMC Public Health 2011, 11:867
http://www.biomedcentral.com/1471-2458/11/867
Page 3 of 6Table 1 Characteristics of participants in the validation study of the MS according to the ATP-III criteria
Self-reported MS Non self-reported MS Confirmed MS Confirmed non-MS Total
n (%) n (%) n (%) n (%) n (%)
Sex
Men 46 (80.7%) 57 (49.6%) 51 (83.6%) 52 (46.8%) 103 (59.9%)
Women 11 (19.3%) 58 (50.4%) 10 (16.4%) 59 (53.2%) 69 (40.1%)
Age
<40 years 5 (8.8%) 41 (35.6%) 4 (6.5%) 42 (37.8%) 46 (26.%)
41-55 years 14 (24.6%) 38 (33%) 12 (19.7%) 40 (36%) 52 (30.2%)
>55 years 38 (66.6%) 36 (31.4%) 45 (73.8%) 29 (26.2%) 74 (43%)
BMI
<30 kg/m
2 37 (64.9%) 104 (90.4%) 37 (60.7%) 104 (93.7%) 142 (82%)
≥30 kg/m
2 20 (35.1%) 11 (9.6%) 24 (39.3%) 7 (6.3%) 30 (18%)
Educational level
Doctorate/Master 11 (19.3%) 29 (25.2%) 12 (19.7%) 28 (25.2%) 40 (23.3%)
Graduate 22 (38.6%) 38 (33%) 26 (42.6%) 34 (30.6%) 60 (34.9%)
Bachelor 24 (42.1%) 48 (41.7%) 23 (37.7%) 49 (44.2%) 72 (41.9%)
Biomedical degree
Yes 13 (22.8%) 50 (43.5%) 14 (22.9%) 49 (44.1%) 63 (36.6%)
No 44 (77.2%) 65 (56.5%) 47 (77.1%) 62 (55.8%) 109 (63.4%)
Total 57 115 61 111 172
BMI body mass index
Table 2 Validity of self-reported MS (Pearson’s chi-square) according to relevant variables and ATP-III and IDF criteria
ATP-III IDF









Total 100 (n =
172)
91.2 (80.7- 97.1) 92.2 (85.7-96.4) 100 (n =
62)
100 (87.2- 100) 97.1 (85.1- 99.9)
Men 59.9 91.3 (79.2-97.6) <0.00
1
84.2 (72.1- 92.5) <0.001 59.7 100 (83.2-100) <0.001 100 (80.5-100) <0.001
Women 40.1 90.9 (58.7-99.8) 100 (93.8-100) 40.3 100 (59.0-100) 94.4 (72.7-99.8)
Age (years)
≤40 26.7 80.0 (28.4-99.5) 100 (91.4-100) 35.5 100 (39.8-100) 100 (81.5-100)
41-55 30.2 78.6 (49.2- 95.3) <0.001 97.4 (86.2- 99.9) <0.001 27.5 100 (54.1-100) <0.001 100 (71.5-100) <0.001
>55 43.1 97.4 (86.2-99.9) 77.8 (60.8-89.9) 37 100 (80.5-100) 83.3 (35.9-99.6)
BMI (kg/m
2)
<30 82 89.2 (85.6- 91.9) <0.001 96.2 (93.6- 96.4) <0.001 66.1 100 (71.5- 100) <0.001 100 (88.4- 100) <0.001




23.2 90.9 (87.9- 93.2) 93.1 (90.8- 94.8) 9.7 100 (54.1- 100) NA
Graduate 34.9 95.5 (93.9- 96.6) <0.001 86.8 (82.6- 90.1) <0.001 37.1 100 (66.4- 100) <0.001 100 (76.8- 100) <0.001
Bachelor 41.9 87.5 (83.4- 90.6) 95.8 (94.4- 96.9) 53.2 100 (73.5- 100) 95.2 (76.2- 99.8)
Biosanitary degree
No 63.4 92.5 (79.6- 98.4) <0.001 87.8 (75.2- 95.4) <0.001 61.3 100 (83.9- 100) <0.001 75 (19.4- 99.4) <0.001
Yes 36.6 84.6 (54.5- 98.1) 94.0 (83.4- 98.7) 38.7 100 (54.1- 100) 100 (81.5- 100)
NA Not applicable. Absence of participants without MS according to IDF criteria in Doctorate/Master group
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As expected, blood pressure was the variable with worse
correlation (r =0 . 4 4p < 0.001 for systolic blood pres-
sure, r =0 . 5p < 0.001 for diastolic blood pressure).
This phenomenon may be due to higher within indivi-
dual day-to-day biological variability. The best correla-
tion was observed for weight and height. In the other
variables the correlation was good (r =0 . 6 8p <0 . 0 0 1
for fasting glucose, r =0 . 5p < 0.001 for HDL-choles-
terol, r =0 . 6 9p < 0.001 for triglyceride, r = 0.95, p <
0.001 for BMI).
There are several validation studies relating to the waist
and hip circumferences [21,22]. They show a sensitivity of
100% and a specificity of 95.7% for men and a sensitivity of
95.1% and a specificity of 97.2% for women to classify in
two groups of abdominal obesity when it is compared to
the gold standard (measurement made by an expert) [21].
Another study showed a trend towards underestima-
tion of waist circumference in women especially in the
group who have a higher obesity abdominal [22]. In our
s t u d yw ef o u n dt h el i m i t a t ion of poor measurement of
waist and hip circumference in clinical practice. How-
ever we found a good correlation between self-reported
waist circumference and waist circumference from med-
ical records (r = 0.96 p < 0.001).
About blood pressure, we should take into account
that there were occasional large fluctuations due to bio-
logical variability. In this context, the participants
reported a single measurement and we collected only
other measurement from medical history. In no case we
had several measurements and in many cases these mea-
surements could be influenced by white coat phenom-
enon or by medication. This last situation has been
taken into account considering as hypertensive those
patients diagnosed with hypertension and those taking
antihypertensive drugs to avoid misclassification.
Isolated arterial hypertension has been previously vali-
dated in a subsample of the SUN cohort with enough
validity [23].
We analyzed the differences between MS and no-MS
and we observed more MS in men than in women and
an increased prevalence with age. No differences were
observed according to university degree. It is possible
that in the SUN cohort there are less MS incidence
than in the general Spanish population because it is a
young cohort (mean age was 37.5 years).
We only could diagnose or rule out MS with informa-
tion found in medical records in 172 of the 336 partici-
pants initially selected. This was a possible limitation of
our study because of the existence of a potential selec-
tion bias. However, the sociodemographic characteristics
and self-reported averaged values for the components of
MS were similar in both groups with no statistically sig-
nificant differences.
We accept that the sample was not representative of the
general population because it is a cohort of university grad-
uates and this could be considered as a limitation in our
study. It is possible that university graduates have better
knowledge about MS and about health in general that gen-
eral population. However, this could be considered also as
a strength of the study because our aim was to validate
self-reported diagnosis of MS and its components among
highly educated subjects (i.e. in this cohort). This would
allow us to use the self-reported information from these
highly educated participants to conduct studies of associa-
tion between various risk factors and this entity. In this
context, we should note that it is not necessary for the
sample to be representative, in the statistical sense of ran-
dom sampling, of the general population. Indeed, the sam-
ple of this 336 selected participants should be
representative of all the SUN cohort participants. This
situation contributes to increase the internal validity of our
results because we are obtaining self-reported information
of high quality. Moreover, uniform education of the cohort
reduces the potential confounding effect by socioeconomic
factors. On the other hand, a strong point of our design is
that participants were unaware that we could get informa-
tion from their medical records after answering their
Table 3 Correlation between self-reported and measured MS variables
Variables Pearson’s r 95% CI Spearman’s Rho 95% CI Intraclass Correlation Coefficient 95% CI
BMI 0.95 0.93- 0.97 0.91 0.88- 0.93 0.93 0.91-0.95
Waist circumferece 0.96 0.92- 0.98 0.96 0.93- 0.98 0.96 0.93-0.98
Glycaemia 0.74 0.65- 0.81 0.78 0.71- 0.84 0.75 0.66-0.82
HDL 0.54 0.39- 0.66 0.87 0.82- 0.90 0.50 0.35-0.63
Triglycerides 0.79 0.65- 0.88 0.87 0.82- 0.90 0.78 0.70-0.84
SBP 0.52 0.38- 0.63 0.58 0.46- 0.67 0.49 0.34-0.61
DBP 0.55 0.42- 0.66 0.61 0.50- 0.70 0.55 0.41-0.65
BMI Body mass index
SBP Systolic blood pressure
DBP Diastolic blood pressure
CI confidence interval
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ficially more precise in their reported data.
Conclusions
Self-reported MS based on self-reported components of
the SM in a Spanish cohort of university graduates was
sufficiently valid as to be used in epidemiological studies.
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